Contract award record
PHE_Scientific_Development of an Ovine Polyclonal Immunoglobulin Therapy.
Notice details
- Published
- Category
- goods
- Buyer region
- London
- Source
- View official notice
Public buyer and contract winner
Public buyer
Public Health Englandawarded to
Contract winner
The Native Antigen CompanyAward value£26,523
- StartCompleted
- AwardedCompleted
- EndCompleted
Work description
This requirement was to develop a rapid and effective therapy against infection by developing an ovine immunoglobulin treatment against the spike protein of Covid 19.
Additional information: PHE discharges its duties as a Category 1 Responder to emergencies on behalf of the Secretary of State for Health within the scope of the Civil Contingencies Act 2004 (CCA 2004). This urgent requirement is in response to the COVID -19 outbreak for the research of therapeutic antibodies.